303 followers
RT @FrontPharmacol: New Research: How can patient preferences be used and communicated in the regulatory evaluation of medicinal products?…
RT @FrontPharmacol: New Research: How can patient preferences be used and communicated in the regulatory evaluation of medicinal products?…
New Research: How can patient preferences be used and communicated in the regulatory evaluation of medicinal products? Findings and recommendations from IMI PREFER and call to action #pharmacology https://t.co/99uTHIq7jp